Abbre viations used : CT, computed tomography; PET, posi tron emission tomography; ROI, region of interest.
Summary:
The effect of age on human striatal dopamine D2 receptors was investigated with positron emission to mography (PET) using [IIC]raciopride as a radioligand. Twenty-one healthy volunteers aged from 20 to 81 years were studied. An equilibrium method was applied and two separate PET scans with different specific activities of [IIC]raciopride were performed. The maximal number of receptors (Bmax) and their dissociation constant (Kd) were calculated using Scatchard analysis. There was an Aging is associated with impairment of motor functions, and extrapyramidal symptoms are rela tively frequent in the elderly (Skre, 1972; Jenkyn and Reeves, 1981) suggesting dysfunction of the brain dopaminergic system during aging. There is both in vitro neuropathological (McGeer et aI., 1977) and neurochemical (Carlsson et aI., 1980; Hornykiewicz, 1983 ) evidence for degeneration of the nigrostriatal dopaminergic system with increas ing age. These abnormalities are, however, less se vere than those seen in Parkinson's disease (Mc Geer et aI., 1977) .
Despite the reductions seen in the number of neu rons in the substantia nigra (McGeer et aI., 1977) and striatal dopamine content (Carlsson et aI., 1980; Hornykiewicz, 1983) the in vitro results concerning the two dopamine receptor subtypes during normal aging have been controversial. Both unchanged (DeKeyser et aI., 1990) and reduced (Seeman et al., 1987; Rinne et aI., 1990 ) striatal D l receptor density have been reported. Many studies have also shown a decline in the number of striatal D2 receptors (Hess et al., 1987; Rinne, 1987; Marshall and Joyce, 1988; Seeman et aI., 1987; Rinne et aI., 1990) whereas other studies have noted no change (De Keyser et al., 1990) or a decrease only in caudate nucleus but not in putamen (Morgan et aI., 1987) .
Nowadays, it is possible to investigate changes in the human brain nigrostriatal dopaminergic system in vivo with positron emission tomography (PET). To visualize the function of the presynaptic part of the nigrostriatal dopaminergic system, ligands such as 6-[ISF]fluorodopa (Garnett et aI., 1984) and [llC] nomifensine (Tedroff et aI., 1988) have been used. The striatal accumulation of 6-[ISF]fluoro dopa has been used to indicate the integrity of pre synaptic dopaminergic terminals. These studies with healthy volunteers have shown contradictory results, because both reduced (Martin et aI., 1989) and unchanged (Sawle et aI., 1990 ) striatal 6-esF]fluorodopa uptake with age have been re ported. There are also several feasible ligands for visualizing brain dopamine receptors in humans in vivo with PET. Wong et al. (1984; found a decrease in N-e lC]methylspiperone binding with age. Later, in a study with C6Br]bromospiperone (Baron et aI., 1986) , a less prominent age-dependent decline in tracer uptake was noted. In these studies, the specific uptake of the ligands was expressed as a ratio between striatal and cerebellar radioactivity (Wong et aI., 1984; Baron et aI., 1986) or using the rate constant of binding (k3) to the receptor (Wong et aI., 1988) . By means of an equilibrium method (Farde et aI., 1986; with two specific activities of the ligand it is possible to estimate the maximal number of binding sites (Bmax) and their dissociation constant (Kd). The purpose of the present study was to investigate with PET possible changes in striatal D2 receptors with age in healthy volunteers.
[llC]Raclopride, a selective dopamine D2 receptor antagonist, was used as radioligand. Moreover, in order to clarify whether the age-related changes in ligand uptake are due to changes in the number of receptors or their affinity, an equilibrium method was used, enabling us to estimate the Bmax and Kd values.
PATIENTS AND METHODS

Subjects
The study population consisted of 21 healthy volun teers (1 2 women and nine men) aged from 20 to 81 years. All the subjects, except two, were right-handed. The sub jects underwent a clinical examination excluding any neu rological or psychiatric disease. Moreover, those >45 years of age were also assessed neuropsychologically. The neuropsychological testing included a language task and tests for object memory, verbal memory, visual mem ory, verbal reasoning, working memory span, vi suo motor speed and visuoconstructive ability. The neuropsycho logical performance of these subjects was normal. Only three of the subjects were taking medication: two persons had mild hypertension (medication: hydrochlorthiazide and hydrochlorthiazide + enalapril), one had glaucoma (medication: timolol eyedrops). None of these drugs is known to affect the brain dopaminergic system. In addi tion, in order to exclude structural brain lesions, a com puterized tomography (CT) scan was carried out for ev ery subject. The CT scans were evaluated by an experi enced neuroradiologist and were considered normal according to the age of the subject in every subject.
Radiochemistry
[1lC]Raclopride was prepared as described previously (Farde et aI., 1988) , with some recent modifications (Ma ziere et aI., 1992).
[IlC]Methyl iodide, prepared by a one pot procedure (Umgstr6m et aI., 1986) from [11C]carbon dioxide produced with an Efremov 103-cm isochronous cyclotron, was thus used in an alkylation reaction of the O-desmethyl precursor (NCQ 259 HBr, Astra, S6dertiilje, Sweden). The volume of the formulated (saline) [1lC]rac lopride solution was determined by weight and division with a density (1.0046 g/ml) of saline. The concentration of [IIC]raclopride was determined separately for each pa tient study by an analytical reversed-phase HPLC system (Waters fJ.Bondapak C18, Millipore Company, Milford, CT, U.S.A.; 30% acetonitrile, 70% 0.05 M phosphoric acid, 2 mllmin) with u.v. detection at 210 nm. Samples of [1lC]raclopride and reference solutions (prepared from raclopride tartrate, Astra) were analyzed in triplicate, the standard deviation being <2%. For the studies with low specific activity of [1 1 C]raclopride , a freshly prepared so lution of raclopride tartrate in saline was added before sterile filtration of the formulated solution. The concen tration of this low specific activity solution of [11C]raclo pride was determined in the same manner as described above for high specific activity study after addition of raclopride tartrate. Thus, the specific activity was deter mined for each study (two for each subject).
The injected dose of [11C]raclopride ranged from 2.4 to 5.8 mCi with specific activities in the order of 56.2 to 280.1 Ci/mmol (mean value 150.5 Cilmmol, high specific activity) and 2.5 to 11.3 mCilmmol (mean value 6.1 Cil mmol, low specific activity). The weight of the injected dose of raclopride was 3.4-33.7 fJ.g (mean 11.6 fJ.g, high specific activity) and 106.3-760 fJ.g (mean 262.4 fJ.g, low specific activity).
PET scanning
Before PET scanning both the left and right antecubital veins were cannulated. The [IlC]raclopride was injected into the right antecubital vein and continuous blood sam ples were taken at regular intervals from the left cannula in order to control that the injection was successful.
Fixation of the head was achieved by using a rapidly hardening polyurethane mass (Insta-foam Productions, Joliet, IL, U.S.A.) supporting the head from the back and sides and shaping itself to the contours of the head. The polyurethane mass was sprayed into a plastic bag placed on a head holder. During the � 30 s that the mass needed to harden, the head of the patient was placed in the right position by using two perpendicular laser beams, one of which ran through the orbitomeatal plane and the other sagittally. At least three points were marked with ink on the skin of the patient along the course of each laser beam so that the head could be placed in the same position during both PET scans.
PET scanning was carried out with an eight-ring whole body PET scanner (ECA T 931108-12) with a spatial reso lution of 5.8-6.5 mm (measured value) and with an axial resolution of 6.8-7.3 mm (measured value). The nonwob ble mode was used.
[IIC]Raclopride uptake was mea sured in the striatum and cerebellum at 0-50 min using 24 time frames. Attenuation correction was determined in dividually for each study using a removable ring source. During this 1O-min transmission scan, about 10 million counts per plane were registered.
The equilibrium method described by Farde et al. (1 986; was used. For each subject, a [llC]raclopride scan was performed twice at least 2 h apart during the same day with both high and low specific activities of the ligand, the exact values of which are given above.
Elliptical regions of interest (ROIs) were drawn on in tegrated images (from 10 to 50 min) on two planes in both hemispheres traversing the striata, which were clearly identifiable. The CT scan was not directly used to guide the ROI placement but was taken, as mentioned previ ously, to exclude structural brain lesions. The average radioactivity in the striatum was determined, and the mean value of the left and right striatum was calculated. The striatum was clearly identifiable, but because reliable separation of the putamen and the caudate nucleus was impossible in the low specific activity study, the tracer uptake was measured only in the whole striatum. Ellipti cal reference ROIs, which included both cortex (hemi spheres, vermis) and some white matter, were drawn on two cerebellar planes accordingly. The average cerebellar radioactivity was used to represent the free compartment of the ligand, since the cerebellum is virtually devoid of dopamine receptors (Martres et aI., 1985; Hall et aI., 1988) . B
and Kd values were calculated using the Scatch ard p:inciple (Scatchard, 1949) . Briefly, for both high and low specific activity study the bound radioactivity (stri atal ' minus cerebellar radioactivity) divided by free (cer ebellar) radioactivity was plotted against bound radioac tivity. In the case of a single receptor population, the Scatchard plot yields a straight line. The reciprocal of its slope is Kd and the intersection point with x axis is Bma x'
These B
and Kd values were correlated with the age of the pati';; �ts. The striatum/cerebellum ratios obtained from the present data were also used for correlation anal yses.
RESULTS
The Bmax values (left and right striatum sepa rately) of the healthy volunteers ranged from 47 to 20 (pmol/ml). The values of the left and right stria tum did not differ significantly (p = 0.27, Wilcoxon signed-rank test), justifying the use of the mean of left and right striatal values in our analysis. There was an age-dependent decline in striatal B m ax values (average from left and right striata) for dopamine D2 receptors (r = -0.49; p = 0.02) (Fig. 1) . The re duction was, on average, 4.6% per decade. When the right and left striatum were analyzed separately, the correlations were r = -0.56 (p = 0.009) for the right and r = -0.36 (p = 0.13) for the left striatum.
The Kd values ranged from 7 to 18 (nM) and showed no left-right difference (p = 0.92, Wilcoxon signed-rank test). As shown in Fig. 2 Kd values changed less with age and the correlation was not statistically significant (r = 0.34, p = 0.13).
Neither the injected dose, nor the specific activ ity or weight of injected dose of raclopride, had a significant correlation with Bmax or Kd values. The results indicate that the reduced striatal uptake of [IIC]raciopride seen during aging is due to a de crease in the number of D2 receptors and not a re sult of a change in their affinity.
The striatum/cerebellum ratio decreased with age (r = -0.65, p = 0.001 for high specific activity and r = -0.58, p = 0.006 for low specific activity). There was a logarithmic association [y = 0.43 times In(54.27x)] between the specific radioactivity used and the striatum/cerebellum ratio. As shown in Fig.  3 , the striatum/cerebellum ratio increases rapidly when the specific activity is in the low range, whereas with high specific activities the effect on the striatum/cerebellum ratio is less pronounced.
DISCUSSION
This is the first time that the effect of aging on
Bmax and Kd values of human striatal dopamine D2 receptors has been studied with PET. The Bmax and
Kd values obtained for striatal D2 receptors are in agreement with those of control subjects of compa rable age in other studies (Farde et aI., 1988; ).
In the present study, Bmax of striatal D2 receptor binding declined with age. Our findings demon strate that the decrease in striatal [11C]raclopride uptake during normal aging is due to a reduced number of receptors, whereas the dissociation con stant (Kd) remains unchanged. The average reduc tion in Bmax was 4.6% per decade. This is of the same magnitude as has been found for the striatum/ cerebellum ratio with C6Br]bromospiperone (Baron et aI., 1986) , which showed a 4% decline per de cade. With N-e IC]methylspiperone the rate of de cline in receptor binding was found to be consider ably greater (Wong et aI., 1984) . In post-mortem studies, the rate of decline in striatal D2 receptor binding has varied between 2.2% and 4.8% per de cade (Seeman et aI., 1987; Rinne et aI., 1990) .
There was large variation in Bmax values in younger subjects. The values were, however, in a range reported previously in the literature (Farde et aI., 1988; . It can not be excluded that there is initially a steeper decline in Bmax in younger sub jects, which levels off in the older age groups. An alternative explanation is that the decline is higher for persons with high initial values and is negligible for those with low initial values. The latter question could only be answered by following up the same individuals and performing e lC]raclopride scans at intervals of a few years. In any event, one should be cautious when drawing conclusions concerning the shape of the aging curve for D2 receptors from the relatively small number of patients in the present study.
When the striata were separated, only Bmax of the right striatum showed a significant decline with age. This may possibly be due to the small number of subjects. The handedness of the subjects remains a possible explanation, but because of the preponder ance of right-handers, it was impossible to investi gate this issue in detail. True asymmetry between the striata in controls seems unlikely, because the individual values of the two striata were not signif icantly different from each other. Farde et ai. (1990) reported that in neuroleptic-naive schizophrenics there was a higher density of D2 receptors in the left putamen but not in the caudate nucleus and that the controls showed symmetrical binding in both hemi spheres.
It has been suggested that the age-dependent de cline in striatal D2 receptors is different between men and women (Wong et aI., 1984) . They found that the decline was linear in women and slightly higher, but exponential, in men over the age range studied. Because of the relatively small number of subjects, men and women were not separated in our material.
In the present study, the striatum/cerebellum ra tio also showed an age-dependent decline. This must, however, be interpreted with caution because there was a significant association between the spe cific radioactivity used and the striatum/cerebellum ratio obtained. Especially with low specific activi ties, a small change in the specific radioactivity of the ligand leads to a substantial change in the stri atum/cerebellum ratio. As evident from Fig. 3 , if one performs only one study and calculates stria tum/cerebellum ratios, the specific activity of the ligand should be relatively high (>50 Ci/mmol), be cause then changes in specific activity do not lead to dramatic changes in the striatum/cerebellum ra tio. Thus, if reliable results that could be used for interindividual comparisons are desired, the spe cific activity should be kept as constant as possible.
It has been suggested that raclopride binding could be interfered with by competition with endog enous dopamine (Seeman et aI., 1989; Young et aI., 1991) . This possibility, however, is not a likely ex planation for our present findings, because if dopa minergic activity is thought to decline with age, it would actually, according to the endogenous dopa mine hypothesis, lead to increased binding with age. Moreover, in a recent study Antonini et ai. (1992) reported that patients with Parkinson's dis ease treated with oral levodopa had unchanged e lC]raclopride uptake as compared with the pre treatment scan, although the disease severity de clined by 50% (indicating increased striatal dopami nergic function). Martin et ai. (1989) showed an age-related de crease in striatal 6-esF]fluorodopa uptake, indicat ing that presynaptic striatal dopaminergic terminals are lost or at least their function is impaired during normal aging. Moreover, the uptake of [llC]SCH 23390 (Schering Corporation, Bloomfield, NJ, U.S.A.), preferentially labelling dopamine Dl re ceptors, was found to decline both in the striatum and in the frontal cortex with age (Suhara et aI., 1991) . These findings, together with those obtained in the present study, suggest that the nigrostriatal do paminergic system degenerates during normal aging.
